Seeking Alpha

Not A Fan Of Auto Stocks - Cramer's Lightning Round (12/8/17)

|
Includes: AAXN, ALKS, GM, IPGP, NUE, S, TMUS, VZ, X
by: SA Editor Mohit Manghnani
Summary

The negative news on Alkermes' drug Vivitrol is a mistake.

Axon Enterprise is a buy.

Nucor is better than US Steel.

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Friday, December 8.

Bullish Calls

Axon Enterprise (NASDAQ:AAXN): Cramer likes the stock. It was formerly Taser.

Alkermes (NASDAQ:ALKS): "I'm partial to Alkermes. I think that Richard Pops has done a good job. There's periodically some negative press on their drug Vivitrol. I think that's a mistake. It's really good."

Sprint (NYSE:S): Sprint is a long-term buy; T-Mobile (NASDAQ:TMUS) is short-term. Buy Verizon (NYSE:VZ) for the income.

Bearish Calls

US Steel (NYSE:X): Why buy US Steel when Nucor (NYSE:NUE) is breaking out and is a better infrastructure play?

General Motors (NYSE:GM): Cramer doesn't like auto stocks at current levels.

IPG Photonics Corporation (NASDAQ:IPGP): The stock is up 100% and it's time to book partial profits.

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Jim Cramer's Action Alerts PLUS: Check out Cramer's multi-million dollar charitable trust portfolio and uncover the stocks he thinks could be HUGE winners. Start your FREE 14-day trial now!

Get Cramer's Picks by email - it's free and takes only a few seconds to sign up